High-dose anthracycline induction in adult acute lymphocytic leukemia

Hematology/Oncology Clinics of North America

Volumn 15, Issue 1, 2001, Pages 9-20

  Todeschini, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTHRAQUINONE; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; RAZOXANE; STEROID; VINCRISTINE; ZORUBICIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

EID: 0035095635     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70197-0     Document Type: Article

References (42)

1. The use of anthracyclines in adult acute lymphoblastic leukemia
2. Acute lymphoblastic leukemia in adults
3. The effects of postinduction intensification with cytarabine and daunorubicin in adult acute lymphoblastic leukemia: A prospective randomized clinical trial by Cancer and Leukemia Group B
4. Bone marrow transplantation versus chemotherapy for maintenance of second remission in childhood acute lymphoblastic leukemia
5. Dose-intensive therapy for adult acute lymphoblastic leukemia
6. Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features
7. Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens
8. Therapy of acute myeloid and acute lymphoblastic leukemia in adults
9. Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia: A randomized phase III study
10. Efficacy of daumorubicin in the therapy of adult acute lymphocitic leukemia: A randomized trial by Cancer and Leukemia Group B
11. Brief intensive therapy for adult acute lymphoblastic leukemia (ALL): Superiority of allogeneic bone marrow transplantation (BMT)
12. The impact of induction anthracycline on long term failure-free survival in childhood acute lymphoblastic leukemia
13. Treatment of acute lymphoblastic leukemia
14. Acute lymphoblastic leukemia in adults: Recent progress, future directions
15. Improved outcome in adult B-cell acute lymphoblastic leukemia
16. Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 patients
17. Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhood
18. Results of treatment with HyperCVAD, a dos-intensive regimen, in adult acute lymphoblastic leukemia
19. Results of vincristine, doxorubicin and dexamethasone regimen in adults with standard and high risk acute lymphoblastic leukemia
20. Combination chemotherapy for acute lymphoblastic leukemia in adults
21. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89
22. Adults and children with small non-cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen
23. Acute toxicity and effectiveness of idarubicin in childhood acute lymphoblastic leukemia
24. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia
25. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: A randomized phase III study
26. Lymphoblastic lymphoma and Burkitt's lymphoma in Caucasian adults: Please don't forget the pediatric experience
27. Management of adult acute lymphoblastic leukemia: Present issues and key challenges
28. Acute lymphoblastic leukemia
29. Acute lymphoblastic leukemia
30. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia: Results of a prospective multicenter randomized trial (PETHEMA ALL-89)
31. Intermittent combination with Adriamycin for childhood acute lymphoblastic leukemia
32. Clinical and cytokinetic aspects of induction of childhood acute lymphoblastic leukemia (ALL): Addiction of an anthracycline to vincristine and prednisone
33. Prognostic value of early response to chemotherapy assessed by the 15 day bone marrow aspiration in adult acute lymphoblastic leukemia: A prospective analysis of 437 cases and its application induction chemotherapy trials
34. Induction toxicity in childhood acute lymphoblastic leukemia: A comparison of two schedules of daunorubicin administration
35. Optimal current treatment of childhood acute lymphoblastic leukemia
36. Small non-cleaved cell lymphoma and leukemia in adults: A retrospective study of 65 adults treated with the LMB pediatric protocols
37. Relationship between daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia
38. Lack of cardiac side effects following high-dose treatment of daunomycin in adult acute lymphoblastic leukemia
39. 81% Event-free survival in advanced Burkitt lymphoma: No difference in outcome between pediatric and adult patients treated with the same intensive pediatric protocol
40. Estimated 6-years event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin
41. A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblatic leukemia
42. Prospective analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience